ArticleJournal for immunotherapy of cancer2021

Bispecific antibody targeting TROP2xCD3 suppresses tumor growth of triple negative breast cancer.

Huicheng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.